Short-term intraocular pressure changes after intravitreal bevacizumab injection

Ali Dehghani; Habib Jafari; Naser Shoeibi

Volume 1, Issue 3 , August 2014, , Pages 93-96

  Intravitreal injections of anti-vascular endothelial growth factors (anti-VEGFs) have become more popular quickly in recent years. Bevacizumab is an anti- vascular endothelial growth factor agent (anti-VEGF) used to treat choroidal neovascularization and retinal vascular disorders. Rare long lasting ...  Read More